- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 18.001 ↑ 0.83%
[as on 14 November, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 3.74% | 0.83% | 1.34% | 2.49% | 1.58% | 11.94% | - | - | - | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 99.01% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.99% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Quantity | Qty change % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.47% | 1244634 | - |
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 7.76% | 258490 | - |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 6.93% | 672796 | - |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 6.84% | 678274 | - |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 5.94% | 207521 | +46.48% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 4.66% | 791979 | +46.99% |
| Ipca Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 4.50% | 637260 | - |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.32% | 544343 | -30.95% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.81% | 200598 | - |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 3.64% | 984676 | - |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.58% | 806343 | - |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 3.55% | 1075015 | - |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.26% | 810813 | - |
| Eris Lifesciences Ltd | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 3.19% | 381673 | - |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 2.64% | 245782 | - |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 2.45% | 464093 | - |
| Acutaas Chemicals Limited | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 2.31% | 331747 | - |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.12% | 202046 | -13.30% |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 2.07% | 258279 | - |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 1.99% | 428454 | - |
| Dr. Lal Path Labs Ltd | LALPATHLAB (INE600L01024) | Healthcare Services | 1.94% | 117984 | - |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 1.89% | 369189 | -5.62% |
| Jubilant Pharmova Limited | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 1.81% | 317568 | - |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.79% | 1772319 | +1.00% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.67% | 368087 | - |
| BAJAJ HEALTHCARE LIMITED | BAJAJHCARE (INE411U01027) | Pharmaceuticals & Biotechnology | 1.34% | 524562 | - |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.29% | 48556 | - |
| Laxmi Dental Limited | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 1.11% | 644434 | - |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 0.14% | 11375 | - |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV history
| Date | NAV |
|---|
| 14 November, 2025 | 18.001 |
| 13 November, 2025 | 17.852 |
| 12 November, 2025 | 17.844 |
| 11 November, 2025 | 17.714 |
| 10 November, 2025 | 17.835 |
| 7 November, 2025 | 17.763 |
| 6 November, 2025 | 17.792 |
| 4 November, 2025 | 17.917 |
| 3 November, 2025 | 18.001 |
| 31 October, 2025 | 17.735 |
| 30 October, 2025 | 17.83 |
| 29 October, 2025 | 17.826 |
| 28 October, 2025 | 17.682 |
| 27 October, 2025 | 17.725 |
| 24 October, 2025 | 17.704 |
| 23 October, 2025 | 17.823 |
| 20 October, 2025 | 17.827 |
| 17 October, 2025 | 17.764 |
| 16 October, 2025 | 17.701 |
| 15 October, 2025 | 17.61 |
| 14 October, 2025 | 17.563 |
| 13 October, 2025 | 17.679 |
| 10 October, 2025 | 17.673 |
| 9 October, 2025 | 17.499 |
| 8 October, 2025 | 17.419 |
| 7 October, 2025 | 17.497 |
| 6 October, 2025 | 17.453 |
| 3 October, 2025 | 17.323 |
| 1 October, 2025 | 17.36 |
| 30 September, 2025 | 17.171 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 18.001 as on 14 November, 2025.
What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 3.74% as on 14 November, 2025.
What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 11.94% as on 14 November, 2025.
